Example: Heart Attack
Search clinical trials for: Antimitotic Agents
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Acute Mountain Sickness and Fatigue
- Aging; Without Mention of Psychosis
- Behavior Changes
- ENT Diseases
- Fibromyalgia, Primary
- Good Visual Acuity for Control
- Hepatocellular Carcinoma in Hepatitis C Virus Infected Patients
- Lung Metastasis Carcinoma
- Parkinson's Disease Dementia (PDD)
- ST Elevated Myocardial Infarction
- Systemic Sclerosis
- Totally Laparoscopic
- Vaginal Birth After Caesarean
- View Full List
Sponsors and Collaborators
- Azienda Ospedaliera Villa Sofia
- Biospect Inc
- Chromis LLC
- Health Future Foundation
- Istanbul Mehmet Akif Ersoy Educational and Training Hospital
- LAT Research
- Minister of Community Development, Mother and Child Health, Zambia
- QIMR Berghofer Medical Research Institute
- Roche s.r.o.
- Royal Bournemouth Hospital
- SPOR CHILD-BRIGHT Network
- University of Montreal (CHUM)
- mehmet ozsurmeli
- View Full List
Drug Interventions
- Allopregnanolone (Allo) with Dexolve in 0.9% saline for injection manufactured by University of California, Davis
- Antibiotics, cefuroxime and metronidazole
- Autologous Conditioned Serum
- CH-4051
- Direct oral anticoagulants (DOACs)
- Grifulvin V® 125 mg/5 mL Suspension, single dose
- Peg-IFN + WB RBV for 48 weeks
- Piperacillin Sodium and Sulbactam Sodium
- Ranexa
- Temisartan/Amlodipine+Rosuvastatin
- Ustekinumab 6 mg/mL
- acetylsalicylic acid stayed for 5 days before surgery
- simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and intravitreal implant of dexamethasone 0.7mg.
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations